Viking Global Investors CVS Health Corp transactions over time
CVS
CVS Health Corp historical holders
total: 20
Transactions details
- Total transactions:
- 3
- New positions:
- 2
- Sold out:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Ole Andreas Halvorsen has been an institutional investor in CVS Health Corp (CVS) since 2018 Q1. According to 2026 Q2 report, Ole Andreas Halvorsen holds 3,663,361 shares with a market value of roughly $378.97M representing 1.08% of their equity portfolio. The fund/company first acquired CVS in 2018 Q1, initially purchasing 950,311 shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in CVS again in 2026 Q2. Since the initial investment, Viking Global Investors has made 2 more transactions in this position.
Does Ole Andreas Halvorsen still hold CVS?
Yes, Ole Andreas Halvorsen continues to hold CVS Health Corp (CVS). According to their 2026 Q2 report, they maintain a position of 3,663,361 shares valued at approximately $378.97M, representing 1.08% of their equity portfolio.
When did Ole Andreas Halvorsen first invest in CVS?
Ole Andreas Halvorsen first invested in CVS Health Corp (CVS) in 2018 Q1 at the reported quarter-end price of $62.21 per share, acquiring 950,311 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for CVS?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for CVS Health Corp (CVS) is approximately $103.45 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in CVS after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in CVS Health Corp (CVS). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $103.45
CVS transactions history by Viking Global Investors
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.